Neith Corporation (TPEX:6236)
Taiwan · Delayed Price · Currency is TWD 19.00
0.00 (0.00%)
Jun 10, 2026, 1:30 PM CST
Neith Market Cap
Neith has a market cap or net worth of 791.43 million as of June 18, 2026. Its market cap has decreased by -32.14% in one year.
Market Cap
791.43M
Enterprise Value
656.88M
Revenue
32.03M
Ranking
n/a
PE Ratio
1,666.16
Stock Price
19.00
Market Cap Chart
Since November 3, 2004, Neith's market cap has increased from 483.77M to 791.43M, an increase of 63.60%. That is a compound annual growth rate of 2.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 791.43M | -11.83% |
| Dec 30, 2025 | 897.64M | -27.93% |
| Dec 27, 2024 | 1.25B | -13.21% |
| Dec 29, 2023 | 1.43B | 166.67% |
| Dec 30, 2022 | 538.12M | 47.83% |
| Dec 30, 2021 | 364.02M | 7.98% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Level Biotechnology | 1.01B |
| GeneReach Biotechnology | 991.34M |
| Lukas Biomedical | 986.14M |
| TCI GENE | 978.96M |
| U-Neuron Biomedical | 955.94M |
| Taiwan Advance Bio-Pharmaceutical | 913.50M |
| Meribank Biotech | 910.81M |
| NatureWise Biotech & Medicals | 869.55M |